Skip to main content
    P

    Picard Medical, Inc. (PMI)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $7.23
    -0.62 (-7.90%)

    Market Cap: $17.78M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Picard Medical, Inc. (PMI) Financials: Revenue, Profit and Cash Flow

    Updated Nov 13, 2026. Financial statements from company filings, amounts in US dollars.

    Picard Medical reported revenue of $4.94M for the fiscal year ended Dec 31, 2025, up 12.5% from the year before. That year, net income was -$27.00M with a net margin of -546.6%, operating cash flow was -$15.67M and free cash flow was -$15.67M. The quarter ended Sep 30, 2026 had revenue of $217.00K and net income of -$2.22M.

    Revenue and Margins

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$4.94M+12.5%-4.1%-268.4%-546.6%
    Dec 2024$4.39M-12.9%-2.6%-312.3%-479.5%
    Dec 2023$5.04M+22.6%-45.8%-307.4%-308.7%
    Dec 2022$4.11MN/A-121.3%-269.1%-271.5%
    Annual, fiscal years ended Dec 2022 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Revenue$4.94M$4.39M$5.04M$4.11M
    Cost of revenue$5.14M$4.50M$7.35M$9.10M
    Gross profit-$204.00K-$112.00K-$2.31M-$4.99M
    Research and development$3.05M$3.38M$2.21M$1.90M
    Operating income-$13.26M-$13.71M-$15.50M-$11.07M
    Net income-$27.00M-$21.05M-$15.57M-$11.17M
    EBITDAN/AN/A-$14.85M-$10.61M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$217.00K$2.95M$1.15M$1.01M$1.19M$2.13M$620.00K$836.00K$881.00K$694.00K$1.98M$826.00K
    Gross profit$95.00K$616.00K$275.00K$815.00K-$130.00K-$127.00K-$358.00K$136.00K-$673.00K-$382.00K$807.00K-$1.11M
    Operating income-$2.10M-$4.63M-$4.51M-$2.55M-$3.49M-$3.52M-$3.25M-$3.57M-$4.44M-$3.82M-$1.87M-$5.91M
    Net income-$2.22M-$5.66M-$7.62M-$4.29M-$10.43M-$6.72M-$5.56M-$8.84M-$6.21M-$4.06M-$1.95M-$5.99M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $6.45M by $1.00M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Total assets$22.55M$12.11M$11.37M$15.44M
    Current assets$20.73M$9.79M$8.76M$12.12M
    Cash and equivalents$7.45M$96.00K$244.00K$152.00K
    Total liabilities$18.76M$35.84M$14.93M$4.07M
    Short-term debt$6.45M$19.98M$4.37M$887.00K
    Long-term debtN/A$0$4.28M$0
    Shareholder equity$3.79M-$44.00M-$3.55M$11.37M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$9.06M$9.17M$11.22M$22.55M$13.52M$11.70M$11.96M$12.11M$12.15M$12.45M$12.41M$11.75M
    Total liabilities$7.73M$7.45M$12.67M$18.76M$5.55M$45.93M$40.62M$35.84M$27.28M$21.82M$17.91M$15.30M
    Cash and equivalents$67.00K$38.00K$121.00K$7.45M$2.81M$410.00K$688.00K$96.00K$6.00K$78.00K$410.00K$244.00K
    Shareholder equity$1.33M$1.72M-$1.45M$3.79M$7.97M-$54.49M-$28.66M-$23.74M-$15.13M-$9.37M-$5.50M-$3.55M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Operating cash flow-$15.67M-$11.87M-$10.63M-$10.72M
    Capital expenditures$0$0$7.00K$29.00K
    Free cash flow-$15.67M-$11.87M-$10.64M-$10.75M
    Investing cash flow$0$0-$9.00K-$37.00K
    Financing cash flow$27.08M$11.74M$10.84M$5.52M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$2.00M-$1.35M-$3.80M-$4.38M-$6.51M-$2.54M-$2.24M-$3.15M-$2.61M-$3.86M-$2.25M-$3.86M
    Capital expendituresN/AN/A$26.00K$0$0$0$0$0$0$0$0$0
    Free cash flowN/AN/A-$3.83M-$4.38M-$6.51M-$2.54M-$2.24M-$3.15M-$2.61M-$3.86M-$2.25M-$3.86M
    Last 12 quarters

    Frequently Asked Questions About PMI

    What is Picard Medical's annual revenue?

    Picard Medical reported revenue of $4.94M for the fiscal year ended Dec 31, 2025.

    How fast is Picard Medical's revenue growing?

    Revenue was up 12.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 6.3%.

    Is Picard Medical profitable?

    No. Picard Medical reported net income of -$27.00M for the fiscal year ended Dec 31, 2025, with a net margin of -546.6%.

    How much free cash flow does PMI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$15.67M minus capital expenditures of $0 produced free cash flow of -$15.67M.

    How much debt does Picard Medical have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $6.45M and cash and equivalents of $7.45M.